Elevated NfL levels were associated with worse clinical outcomes in COVID-19 patients, with high concentrations reported in critically ill COVID-19 patients and enhancing the prediction of COVID-19 mortality [19,27,28]. The gene discussed is NEFL; the disease is COVID-19.